ArticleJournal of Cancer2017

Combined Targeting of mTOR and Akt Using Rapamycin and MK-2206 in The Treatment of Tuberous Sclerosis Complex.

Shuang Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.